RT Book, Section
A1 Dirkx, Tonja C.
A1 Woodell, Tyler B.
A2 Papadakis, Maxine A.
A2 McPhee, Stephen J.
A2 Rabow, Michael W.
A2 McQuaid, Kenneth R.
SR Print(0)
ID 1193127290
T1 Nephritic Spectrum Glomerular Diseases
T2 Current Medical Diagnosis & Treatment 2023
YR 2023
FD 2023
PB McGraw-Hill Education
PP New York, NY
SN 9781264687343
LK accessmedicine.mhmedical.com/content.aspx?aid=1193127290
RD 2024/04/24
AB Key  Clinical  Updates  in  Nephritic  Spectrum  Glomerular  DiseasesSGLT2-inhibitors  may  be  added  to  standard  care  in  the  well-selected  patient.  Corticosteroids  for  reducing  proteinuria  and  slowing  progression;  however,  may  be  considered  for  patients  with  GFR  greater  than  30  mL/min/1.73  m2  and  persistent  proteinuria  greater  than  1  g/day  despite  maximal  ACE  inhibitor  or  ARB.Cheung  CK  et  al.  J  Clin  Med.  [PMID:  34200024]